COVID-19 has had a major impact on healthcare staff, patients and health systems in Europe. The Commission has proposed a €9.4 billion funding programme to strengthen the EU’s crisis management and health systems.
This is the first follow-up action envisaged by the Union toolbox for the use of mobile apps to support contact tracing in response to the coronavirus pandemic presented on 16 April 2020.
Due to the coronavirus pandemic, the consultation period, initially scheduled to end on 7 May, has been extended until 21 May. All interested stakeholders are invited to contribute to the shaping of future cancer policies and actions.
President von der Leyen will host a global online pledging event. The initial goal is to reach €7.5 billion worth of pledges. The money collected will help accelerate the development and deployment of universally available and affordable vaccination, treatment and diagnostics.
These recommendations are an important part of the overall strategy in finding treatments and a vaccine to protect citizens against the coronavirus.
The European Commission welcomes the adoption by the European Parliament and the Council of the proposal to postpone by one year the date of application of the Medical Devices Regulation.
The document explains some regulatory flexibilities that can be applied to help pharmaceutical companies cope with the consequences of the pandemic, while ensuring a high level of quality, safety and efficacy for medicinal products made available to patients in the EU.
EU Member States, supported by the Commission, adopted an EU toolbox to use mobile applications for efficient contact tracing and warning in response to the coronavirus pandemic.
Large-scale testing helps detect and slow down the COVID19 pandemic, paving the way for a gradual return to our normal lives. The new guidelines are crucial for the European Roadmap towards lifting coronavirus containment measures.
The Guidance document aims to facilitate a common approach across EU Member States to the donation, collection, testing, processing, storage, distribution and monitoring of convalescent plasma for the treatment of Covid-19 patients.